Publicly Traded Cannabis Stock News
Perhaps the biggest threat to the legal Canadian medical cannabis industry is the competition from the illegal dispensaries that operate openly in many parts of the country, especially in...
Terra Tech and Blum Announce Definitive Merger Agreement Company acquires one of California’s highest-volume medical cannabis dispensaries NEWPORT BEACH, Calif., Jan. 12, 2016 /PRNewswire/ — Terra Tech Corp. (OTCQX: TRTC) (“Terra...
Tweed, the flagship brand of Canopy Growth, operates out of a former Hershey factory in Ontario, and, with changing laws, CEO Bruce Linton hopes that the company could come...
In yet another sign of the cannabis industry becoming more mainstream, the Extreme Tech Challenge, which is taking place now (live webcast) at the CES in Las Vegas, includes...
Dean Chaykowski, a contributor to Seeking Alpha, has written an extensive review of Canopy Growth (TSX Venture: CGC) that serves as a great introduction to the theme of investing in...
Sacramento Bee reporter Peter Hecht explores the emergence of the cannabis industry, which is drawing investors like cannabis-industry focused Poseidon Asset Management and Privateer Holdings but also more diversified firms including...
Aurora Cannabis is the first approved licensed producer of cannabis in Alberta and recently won its license to sell after being approved to cultivate in February. The technologically advanced...
Each month, Alan Brochstein of 420 Investor publishes a comprehensive review of the publicly traded cannabis-related stocks and discusses several key topics. The November edition included: Market Review and Outlook...
Aphria Announces Licence Amendment LEAMINGTON, ONTARIO–(Marketwired – Dec. 31, 2015) – Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) announces today an amendment to its licence by Health Canada,...
Alan Brochstein published an article on the publicly-traded Canadian cannabis stocks, including Aphria, Aurora Cannabis, Canopy Growth, Emerald Health, Mettrum, OrganiGram, PharmaCan Capital and Supreme Pharma. The article, which is...
One of the most exciting aspects of the global cannabis legalization has been the progress since the 2014 implementation of the federally legal medical cannabis program in Canada, MMPR,...
GW Pharmaceuticals (NASDAQ: GWPH) reported yesterday that Founder and Chairman Geoffrey Guy has sold about 100K shares, with the majority of the sales taking place on Friday, December 18th. The...
MassRoots (OTC: MSRT) CEO Isaac Dietrich published a 2015 Review and 2016 Outlook this evening that was emailed by the company. The letter detailed significant progress on a number of fronts...
Organigram Holdings Announces Annual and Fourth Quarter Results for Fiscal 2015 Organigram Attains Breakeven Cash Flow in Q1 MONCTON, NEW BRUNSWICK–(Marketwired – Dec. 17, 2015) – Organigram Holdings Inc....
Aphria’s Revenues Cross Break-Even Threshold Sales Climb 114% in Second Quarter LEAMINGTON, ONTARIO–(Marketwired – Dec. 17, 2015) – Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) is pleased to...
It’s a regular event that a cannabis company instantly loses its Instagram account without warning. Nate Nichols shares the recent details of Baked Bros, which, according to co-founder Nadeem Al-Hasan...
Mettrum Receives Third Health Canada License for Its 60,000 Square Foot State-of-the-Art Production and Distribution Facility – Total licensed production capacity increases to 3,500 kilograms per annum – Health...
The Economist explores the opportunity for Canada to legalize cannabis for adult use, extending upon its current medical cannabis program. It concludes: The existence of companies like Tweed, which obtained...
In a recent interview, Canadian licensed medical cannabis producer Aphria (TSX Venture: APH) CEO Vic Neufeld discussed that wholesaling to other licensed producers (LPs) accounted for about 20-25% of...
Research analyst Derik De Bruin, who has been at Bank of America Merrill Lynch as its lead analyst for the Life Sciences Tools and Diagnostics sector since 2011 following...
CEO Daniel Yazbeck of MyDx Inc. (OTC: MYDX) interviews with David Friedman, CEO of MJIC Media, LLC at the Cannabis Growth Capital Conference in Las Vegas, NV in November....
GW Pharmaceuticals (NASDAQ: GWPH) reported its fiscal year-end results today and held a conference call after the market closed. One of the more interesting parts of the prepared remarks involved...
Pharmaceutical CBD (cannabidiol) Shows Promise for Children with Severe Epilepsy Significant seizure reduction in studies using CBD in combination with AEDs PHILADELPHIA, December 7, 2015 – Around the globe...
After the market close, Supreme Pharma announced that it will receive its pre-license inspection on December. The company, along with several others, has been waiting all year for an...
We publish a lot of content on the Canadian cannabis industry at New Cannabis Ventures. 15% of our visitors reside in Canada, perhaps consequently, and I spend a great deal of...
